(Q34450732)

2 August 2017

1 reference

title

Update on ankylosing spondylitis: current concepts in pathogenesis (English)

1 reference

2 August 2017

main subject

ankylosing spondylitis

1 reference

Judith A Smith

1

1 reference

2 August 2017

publication date

1 January 2015

1 reference

Current Allergy and Asthma Reports

2 August 2017

published in

1 reference

2 August 2017

volume

15

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

489

1 reference

The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Ankylosing spondylitis: what is the cost to society, and can it be reduced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Treatment update on spondyloarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

An update on the contribution of the MHC to AS susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

HLA-B27 misfolding and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

HLA-B27 subtype oligomerization and intracellular accumulation patterns correlate with predisposition to spondyloarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Cytokines that regulate autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

IL-12 and IL-23: master regulators of innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Identification of GPR65, a novel regulator of matrix metalloproteinases using high through-put screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

T-bet: a bridge between innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Innate T cell responses in human gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Microbes, the gut and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Genetics of spondyloarthritis--beyond the MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Inflammatory pathways in spondyloarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Wnt signaling in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

The crystal structure of human endoplasmic reticulum aminopeptidase 2 reveals the atomic basis for distinct roles in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

HLA-B27, but not HLA-B7, immunodominance to influenza is ERAP dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

ERAP1 structure, function and pathogenetic role in ankylosing spondylitis and other MHC-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

The critical role of interleukin-23 in spondyloarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Does the microbiome play a causal role in spondyloarthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Gut inflammation and spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Sost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

21 January 2018

12 December 2020

Genetics of ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-014-0489-6

Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis

21 January 2018

1 reference

12 December 2020

The Role of HLA-B27 in Spondyloarthritis

1 reference

12 December 2020

1 reference

12 December 2020

Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives

1 reference

12 December 2020

Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements

1 reference

12 December 2020

Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis

1 reference

12 December 2020

Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease

1 reference

12 December 2020

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

1 reference

12 December 2020

The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study

1 reference

12 December 2020

ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice.

1 reference

12 December 2020

Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis

1 reference

12 December 2020

Review: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond

1 reference

12 December 2020

Extra-articular manifestations in psoriatic arthritis patients

1 reference

12 December 2020

10.1007/S11882-014-0489-6

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1040019907

0 references

1 reference